ICH Q1A – Page 24 – Pharma.Tips

How to Investigate Unexpected Assay Loss During Photostability Testing

Effective Steps to Investigate Unexpected Assay Loss in Photostability Testing Unexpected assay loss during photostability testing can disrupt pharmaceutical stability studies and compromise regulatory compliance. This article outlines practical steps…

FDA and EMA Expectations for Stability Data in New Drug Submissions

Understanding and Meeting Regulatory Expectations for Stability Studies in Drug Submissions In the pharmaceutical industry, regulatory expectations for stability studies represent a critical aspect of ensuring drug quality and efficacy.…

Why Photostability Studies Fail Despite Following ICH Q1B Exposure Conditions

Troubleshooting Photostability Study Failures in Compliance with ICH Q1B In the pharmaceutical industry, the integrity and efficacy of drug products are crucial, and photostability studies serve as a benchmark for…

Why Photostability Studies Fail Despite Following ICH Q1B Exposure Conditions

Addressing Photostability Study Failures: Recommendations for Compliance and Quality Assurance In the realm of pharmaceutical manufacturing, ensuring the quality and stability of products is paramount. One common challenge that arises…

Stability Failures and OOT? Stability Program Solutions

Addressing Stability Study Failures and OOT Signals: Practical Solutions Stability studies are pivotal in ensuring the quality and shelf life of pharmaceutical products. However, encountering out-of-trend (OOT) results or outright…

Poor Stability Study Design Leading to Rejections? Common Errors Explained

Understanding and Addressing Common Stability Study Design Errors In the rigorous field of pharmaceutical manufacturing, the integrity of stability studies is paramount to ensuring product safety and efficacy throughout its…

Stability Failures Like Degradation? Investigation and Shelf-Life Fixes

Investigation and Solutions for Stability-Induced Defects Stability failures, especially those resulting in degradation pathways, can severely impact product quality and shelf life, leading to out-of-specification (OOT) or out-of-trend (OOS) results.…

Stability Failures and OOT Trends? Shelf-Life Management Solutions From Protocol to CAPA

Managing Stability Failures and OOT Trends Through Effective Shelf-Life Strategies In the pharmaceutical industry, stability failures and out-of-trend (OOT) excursions can pose significant challenges to product integrity and compliance. When…